CYTK

NASDAQ HEALTHCARE

Cytokinetics Inc

$80.20

$1.81 (+2.32%)

Live quote

52w: $32.89 – $88.31

Loading chart…

P/E Ratio—

P/B Ratio—

EV/EBITDA—

Debt/Equity—

ROE—

ROIC—

Revenue Growth376.56%

Gross Margin—

Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering, developing and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company is headquartered in South San Francisco, California.

Own CYTK? Track it here.

Create a free account to add CYTK to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account